| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 347 | 320 | +8.7% |
| EBITDA | 40.8 | 34.4 | +18.8% |
| EBITDA margin | 11.8% | 10.8% | +1.0 pts |
| Profit before tax | 30.1 | 27.6 | +8.9% |
| Net profit | 22.1 | 20.6 | +7.0% |
| EPS | ₹18.00 | ₹16.83 | +7.0% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1,183 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 8.7 | 8.7 | 15.2 | 12.9 | 9.9 | ||
| 154 | 154 | 168 | 123 | 94.0 | ||
| 1,329 | — | — | — | — | ||
| 1,058 | 1,030 | 901 | 934 | 1,006 | ||
| — | +14.4% | −3.6% | −7.2% | — | ||
| 124 | 118 | 99.2 | 113 | 123 | ||
| 11.7% | 11.5% | 11.0% | 12.1% | 12.2% | ||
| 94.7 | 89.5 | 74.2 | 91.2 | 104 | ||
| 65.4 | 64.0 | 38.9 | 53.6 | 61.1 | ||
| 6.2% | 6.2% | 4.3% | 5.7% | 6.1% | ||
| ₹53.34 | ₹52.17 | ₹31.75 | ₹43.70 | ₹49.84 | ||
| — | +64.3% | −27.3% | −12.3% | — | ||
| — | 85.5 | 25.2 | 29.9 | 58.2 | ||
| — | −45.8 | −33.6 | −33.2 | −37.4 | ||
| 39.8 | 39.8 | −8.4 | −3.4 | 20.9 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 1,183.2 | |
| - Cash, Equiv & ST Investments | 9.9 | 12.9 | 15.2 | 8.7 | 8.7 | |
| + Total Debt | 94.0 | 122.8 | 167.9 | 154.2 | 154.2 | |
| Enterprise Value | — | — | — | — | 1,328.7 | |
| Revenue | 1,006.2 | 934.2 | 900.5 | 1,029.8 | 1,057.5 | |
| Growth %, YoY | — | -7.2 | -3.6 | +14.4 | — | |
| EBITDA | 122.6 | 113.4 | 99.2 | 118.1 | 124.1 | |
| Margin % | 12.18 | 12.14 | 11.01 | 11.47 | 11.74 | |
| EBIT | 103.6 | 91.2 | 74.2 | 89.5 | 94.7 | |
| Net Income | 61.1 | 53.6 | 38.9 | 64.0 | 65.4 | |
| Margin % | 6.07 | 5.74 | 4.32 | 6.21 | 6.18 | |
| EPS, Adj (current shares) | 49.84 | 43.70 | 31.75 | 52.17 | 53.34 | |
| Growth %, YoY | — | -12.3 | -27.3 | +64.3 | — | |
| Cash from Operations | 58.2 | 29.9 | 25.2 | 85.5 | — | |
| Capital Expenditures | -37.4 | -33.2 | -33.6 | -45.8 | — | |
| Free Cash Flow | 20.9 | -3.4 | -8.4 | 39.8 | 39.8 | |
Prices at the previous close · figures from the company's filings with NSE
Punjab Chemicals & Crop Protection (NSE: PUNJABCHEM) had a market capitalisation of ₹1,183 crore at the previous close (₹965.10 a share), a PE ratio of 18.1 on the last four quarters' profit and a price-to-book ratio of 2.79. In FY26 its consolidated net profit was ₹64 crore on revenue of ₹1,030 crore; in Q1 FY27 (April–June 2026) it was ₹22.1 crore, up 7.0% year on year. Its debt-to-equity ratio was 0.36 on 31 March 2026. Promoters held 39.24% of the shares on 30 September 2026.
Punjab Chemicals & Crop Protection's PE ratio is 18.1 at the previous close (₹965.10 a share): a market capitalisation of ₹1,183 crore divided by consolidated net profit of ₹65.4 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹64 crore) it is 18.5.
Punjab Chemicals & Crop Protection's price-to-book (PB) ratio is 2.79 at the previous close: a market capitalisation of ₹1,183 crore divided by shareholders' equity (book value) of ₹423 crore on 31 March 2026. That is a book value of ₹345.41 per share against a share price of ₹965.10.
Punjab Chemicals & Crop Protection's net worth — shareholders' equity in its consolidated balance sheet — was ₹423 crore on 31 March 2026, up 16.1% from ₹365 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,183 crore at the previous close.
Punjab Chemicals & Crop Protection's market capitalisation was ₹1,183 crore at the previous close: 1.23 crore shares at ₹965.10 each.
Punjab Chemicals & Crop Protection's debt-to-equity ratio was 0.36 on 31 March 2026: borrowings of ₹154 crore against total equity of ₹423 crore. A year earlier, on 31 March 2025, it was 0.46.
Punjab Chemicals & Crop Protection's basic earnings per share (EPS) were ₹52.17 in FY26, against ₹31.75 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹53.34.
No. Punjab Chemicals & Crop Protection had borrowings of ₹154 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.36. Its cash and current investments were ₹15 crore, so its net debt was ₹139 crore.
Punjab Chemicals & Crop Protection's book value per share was ₹345.41 on 31 March 2026: shareholders' equity of ₹423 crore divided by the 1.23 crore shares in issue, up 16.1% from ₹297.48 a year earlier. The share price at the previous close was ₹965.10.
Punjab Chemicals & Crop Protection's dividend yield is 0.31% at the previous close: dividends of ₹3 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹965.10. They were ₹3 on 17 July 2026.
In FY26, Punjab Chemicals & Crop Protection's return on equity (ROE) was 16.2% and its return on capital employed (ROCE) was 19.0%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 11.2% and ROCE 17.3%.
Promoters held 39.24% of Punjab Chemicals & Crop Protection on 30 September 2026, unchanged from the previous quarter and up 0.02 percentage points from 39.22% a year earlier, according to the shareholding pattern filed with NSE.
On 30 September 2026, Punjab Chemicals & Crop Protection's shares were held by promoters 39.24%, foreign portfolio investors (FII/FPI) 6.66%, domestic institutions (DII) 0.74% (including mutual funds at 0.01%) and retail and other non-institutional investors 53.37%. Over the year, FII holding was up 3.64 percentage points from 3.02% and DII holding was up 0.18 percentage points from 0.56%.
In 2026, Punjab Chemicals & Crop Protection has declared one dividend: ₹3 with record date 17 July 2026.
In FY26, Punjab Chemicals & Crop Protection generated ₹85.5 crore of cash from operations and spent ₹45.8 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹39.8 crore. In FY25 it was −₹8.4 crore.
Punjab Chemicals & Crop Protection will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
Punjab Chemicals & Crop Protection's latest results are for Q1 FY27 (April–June 2026), filed on 31 July 2026: consolidated net profit ₹22.1 crore, up 7.0% from ₹20.6 crore in Q1 FY26; revenue from operations ₹347 crore, up 8.7% year on year.
In FY26 (April 2025–March 2026), Punjab Chemicals & Crop Protection's consolidated net profit was ₹64 crore, up 64.3% from ₹38.9 crore in FY25, on revenue from operations of ₹1,030 crore (up 14.4%). Over three years, from FY23, net profit was up 4.7%.
In FY26, Punjab Chemicals & Crop Protection earned net profit of ₹64 crore on revenue of ₹1,030 crore, against ₹80.9 crore on ₹448 crore for Astec LifeSciences. Punjab Chemicals & Crop Protection's operating margin was 8.7% (Astec LifeSciences −11.0%) and its return on equity 16.2% (Astec LifeSciences −25.9%).
On FY26 consolidated figures, against Astec LifeSciences, Meghmani Organics and India Pesticides: Punjab Chemicals & Crop Protection's operating margin of 8.7% is the second highest of the four (Astec LifeSciences −11.0%, Meghmani Organics 2.6%, India Pesticides 14.4%; peer average 2.0%); its return on equity of 16.2% is the highest of the four (Astec LifeSciences −25.9%, Meghmani Organics 1.9%, India Pesticides 12.6%; peer average −3.8%); its revenue growth over three years of 0.8% a year is the second highest of the four (Astec LifeSciences −10.7% a year, Meghmani Organics −5.2% a year, India Pesticides 6.1% a year; peer average −3.2% a year).
From Punjab Chemicals & Crop Protection's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.